Received Mar 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 1 | Y008483 | — |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 2 | Y006393 | — |
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | 3 | Y005465 | — |
No additional AE reported; immunization coordinator calling to report T/E for VAQTA , PEDVAX HIB , VAXNEUVANCE that was administered. T/E date was on 2/18/2025 and VAQTA , PEDVAX HIB , VAXNEUVANCE were administered on 2/19/2025.; This spontaneous report was received from a Nurse regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, past drug reactions and allergies were not reported. On 18-FEB-2025, a temperature excursion (TE) occurred for Hepatitis A Vaccine, Inactivated (VAQTA), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB) and Pneumococcal 15-valent Conjugate Vaccine (VAXNEUVANCE) at 32 degree Fahrenheit (F) for 2 hours and 12 minutes, with not previous TE. After the TE, on 19-FEB-2025, the patient was vaccinated with an improperly stored dose of Hepatitis A Vaccine, Inactivated (VAQTA) 25U/0.5 ml Injection, prefilled syringe, first dose (lot number Y008483 has been verified to be valid for Hepatitis A Vaccine, Inactivated [VAQTA], expiration date 26-Nov-2025); with an improperly stored dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB), second dose (lot number Y006393 has been verified to be valid for Haemophilus b Conjugate Vaccine [Meningococcal Protein Conjugate] [LIQUID PEDVAX HIB], expiration date 07-Nov-2026; formulation was not provided) and with an improperly stored dose of Pneumococcal 15-valent Conjugate Vaccine (VAXNEUVANCE), 0.5 ml Injection, prefilled syringe, third dose (lot number Y005465 has been verified to be a valid number for Pneumococcal 15-valent Conjugate Vaccine [VAXNEUVANCE], expiration date 08-Jan-2027); all vaccines were administered as prophylaxis (exact dose, route of administration and anatomical site of injection were not reported for any of the vaccines) (Product storage error). No additional adverse event was reported for the patient (No adverse event). This is one of several reports from the same reporter.; Sender's Comments: Priority : 5 , Is case serious : No , MNSC number : 02763807-02763516 , CLIC number : , ESTAR number : , IRMS number : 500UW00000VCgbGYAT|04032025230033|5967 , Central date : 2025-03-05 , Classification : DMC, Attachment description : NSC Call , Safety case number : , MNSC case number : 02763807 , MNSC interaction number : 02763516 , Integration log UniqueID : 500UW00000VCgbGYAT|04032025230033|5967 , Service cloud CaseID : 500UW00000VCgbGYAT